ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Supernus Pharmaceuticals Inc. (SUPN) on Monday reported a loss of $58.4 million in its second quarter.

The Rockville, Maryland-based company said it had a loss of $1.01 per share. Earnings, adjusted for asset impairment costs and amortization costs, came to 54 cents per share.

The drugmaker posted revenue of $219.1 million in the period.

Supernus expects full-year revenue in the range of $860 million to $890 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SUPN at https://www.zacks.com/ap/SUPN